-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
0142178215
-
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
-
King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-6.
-
(2003)
Science
, vol.302
, pp. 643-646
-
-
King, M.C.1
Marks, J.H.2
Mandell, J.B.3
-
3
-
-
38049171118
-
Variation of breast cancer risk among BRCA1/2 carriers
-
Begg CB, Haile RW, Borg A, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008;299:194-201.
-
(2008)
JAMA
, vol.299
, pp. 194-201
-
-
Begg, C.B.1
Haile, R.W.2
Borg, A.3
-
4
-
-
33645242182
-
Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations
-
Savas S, Schmidt S, Jarjanazi H, Ozcelik H. Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations. Human Genomics 2006;2:287-96.
-
(2006)
Human Genomics
, vol.2
, pp. 287-296
-
-
Savas, S.1
Schmidt, S.2
Jarjanazi, H.3
Ozcelik, H.4
-
5
-
-
34247634643
-
Estrogen receptor a (ESR1) gene amplification is frequent in breast cancer
-
Holst F, Stahl PR, Ruiz C, et al. Estrogen receptor a (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007;39:655-60.
-
(2007)
Nat Genet
, vol.39
, pp. 655-660
-
-
Holst, F.1
Stahl, P.R.2
Ruiz, C.3
-
6
-
-
36048968279
-
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies
-
Gonzalez-Neira A, Rosa-Rosa JM, Osorio A, et al. Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies. BMC Genomics 2007;8:299.
-
(2007)
BMC Genomics
, vol.8
, pp. 299
-
-
Gonzalez-Neira, A.1
Rosa-Rosa, J.M.2
Osorio, A.3
-
7
-
-
0028138404
-
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9
-
Ochieng J, Fridman R, Nangia-Makker P, et al. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 1994;33:14109-14.
-
(1994)
Biochemistry
, vol.33
, pp. 14109-14114
-
-
Ochieng, J.1
Fridman, R.2
Nangia-Makker, P.3
-
9
-
-
0027414461
-
Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma
-
Lotz MM, Andrews CW, Jr., Korzelius CA, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A 1993;90:3466-70.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 3466-3470
-
-
Lotz, M.M.1
Andrews Jr., C.W.2
Korzelius, C.A.3
-
10
-
-
37549002157
-
Galectin-3 cleavage: A novel surrogate marker for matrix metalloproteinase activity in growing breast cancers
-
Nangia-Makker P, Raz T, Tait L, Hogan V, Fridman R, Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res 2007;67:11760-8.
-
(2007)
Cancer Res
, vol.67
, pp. 11760-11768
-
-
Nangia-Makker, P.1
Raz, T.2
Tait, L.3
Hogan, V.4
Fridman, R.5
Raz, A.6
-
11
-
-
0029557241
-
Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line
-
Nangia-Makker P, Thompson E, Hogan V, Ochieng J, Raz A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 1995;7:1079-87.
-
(1995)
Int J Oncol
, vol.7
, pp. 1079-1087
-
-
Nangia-Makker, P.1
Thompson, E.2
Hogan, V.3
Ochieng, J.4
Raz, A.5
-
12
-
-
0026351389
-
Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis
-
Zhang RD, Fidler IJ, Price JE. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991;11:204-15.
-
(1991)
Invasion Metastasis
, vol.11
, pp. 204-215
-
-
Zhang, R.D.1
Fidler, I.J.2
Price, J.E.3
-
13
-
-
26844578050
-
In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line
-
Hoffmeyer MR, Wall KM, Dharmawardhane SF. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell Int 2005;5:11.
-
(2005)
Cancer Cell Int
, vol.5
, pp. 11
-
-
Hoffmeyer, M.R.1
Wall, K.M.2
Dharmawardhane, S.F.3
-
14
-
-
34748819978
-
Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans
-
Keinan A, Mullikin JC, Patterson N, Reich D. Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans. Nat Genet 2007;39:1251-5.
-
(2007)
Nat Genet
, vol.39
, pp. 1251-1255
-
-
Keinan, A.1
Mullikin, J.C.2
Patterson, N.3
Reich, D.4
-
15
-
-
33646570913
-
A genome wide linkage search for breast cancer susceptibility genes
-
Smith P, McGuffog L, Easton DF, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 2006;45:646-55.
-
(2006)
Genes Chromosomes Cancer
, vol.45
, pp. 646-655
-
-
Smith, P.1
McGuffog, L.2
Easton, D.F.3
-
17
-
-
0036510564
-
Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest
-
Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002;277:6852-7.
-
(2002)
J Biol Chem
, vol.277
, pp. 6852-6857
-
-
Yoshii, T.1
Fukumori, T.2
Honjo, Y.3
Inohara, H.4
Kim, H.R.5
Raz, A.6
-
18
-
-
2442684458
-
Endogenous galectin-3 determines the routing of CD95apoptot ic signaling pathways
-
Fukumori T, Takenaka Y, Oka N, et al. Endogenous galectin-3 determines the routing of CD95apoptot ic signaling pathways. Cancer Res 2004;64:3376-9.
-
(2004)
Cancer Res
, vol.64
, pp. 3376-3379
-
-
Fukumori, T.1
Takenaka, Y.2
Oka, N.3
-
19
-
-
0034101698
-
Concentrations of galectin-3 in the sera of normal controls and cancer patients
-
Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 2000;6:1389-93.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1389-1393
-
-
Iurisci, I.1
Tinari, N.2
Natoli, C.3
Angelucci, D.4
Cianchetti, E.5
Iacobelli, S.6
-
20
-
-
9644269159
-
Alterations in galectin-3 expression and distribution correlate with breast cancer progression: Functional analysis of galectin-3 in breast epithelial-endothelial interactions
-
Shekhar MP, Nangia-Makker P, Tait L, Miller F, Raz A. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions. Am J Pathol 2004;165:1931-41.
-
(2004)
Am J Pathol
, vol.165
, pp. 1931-1941
-
-
Shekhar, M.P.1
Nangia-Makker, P.2
Tait, L.3
Miller, F.4
Raz, A.5
-
21
-
-
0033888016
-
Galectin-3 induces endothelial cell morphogenesis and angiogenesis
-
Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000;156:899-909.
-
(2000)
Am J Pathol
, vol.156
, pp. 899-909
-
-
Nangia-Makker, P.1
Honjo, Y.2
Sarvis, R.3
|